German regulators want statin APIs made by Artemis Biotech to be banned after finding deviations good manufacturing practice (GMP) at the firm’s facility in Hyderabad, India.
India-based Dr Reddy's Laboratories has boosted its revenue by 168
per cent for the 2006 year, fuelled by a strengthening position in
the international market.
Dr Reddy's Laboratories has started first clinical trials of a
"four-in-one" polypill clinical trial, which could revolutionise
the cardiovascular drugs market.
Looking for $45m (€35m) in savings, Teva has decided to abandon its
drug manufacturing plant in Cidra, Puerto Rico, as it scrambles to
adjust capacity seven months after its acquisition of Ivax.
The global generics industry is growing at such a rate that it can
now support billion dollar companies, with activities crossing into
active pharmaceutical ingredient (API) production and R&D. This
shift in the sector - from...